Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. - Wikidata - wikimedia - TriplyDB

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

http://www.wikidata.org/entity/Q35099518

about

Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes Effects of PTH on osteocyte function Role of vitamin D in diabetes mellitus and chronic kidney disease Roles of the kidney in the formation, remodeling and repair of bone Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment.FGF23 in Acute and Chronic Illness Arterial calcification in chronic kidney disease: key roles for calcium and phosphate Fibroblast growth factor 23 Bone disease in pediatric chronic kidney disease Fibroblast Growth Factor 23: A New Dimension to Diseases of Calcium-Phosphorus Metabolism Phosphorus and the kidney: What is known and what is needed Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease Cardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular Disease Phosphate control in dialysis Contextual poverty, nutrition, and chronic kidney disease FGF23 signaling impairs neutrophil recruitment and host defense during CKD.Calcium and phosphate impact cardiovascular risk.FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney disease.Fibroblast Growth Factor-23-A Potential Uremic Toxin Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability Biomarkers in chronic kidney disease, from kidney function to kidney damage Aortic calcification and femoral bone density are independently associated with left ventricular mass in patients with chronic kidney disease The Role of Emerging Risk Factors in Cardiovascular Outcomes Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments.Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis Decreased cortical thickness, as estimated by a newly developed ultrasound device, as a risk for vertebral fracture in type 2 diabetes mellitus patients with eGFR of less than 60 mL/min/1.73 m2.A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease.Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4 Calcium Balance in Chronic Kidney Disease.Soluble klotho may be a marker of phosphate reabsorption.FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts.The use of fibroblast growth factor 23 testing in patients with kidney disease.Calcium balance and negative impact of calcium load in peritoneal dialysis patients.Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients.Phosphate metabolism modulation in chronic kidney disease: when, how and to what extent?

P2860

Q24604832-77CE6059-D947-44A7-841F-31D11547800F Q24631082-0E14C9A4-394D-4D87-9432-4E8146C682C7 Q26765231-C5BA12CD-1FC4-4EED-BA35-A52C6098A8DD Q26768186-91B50176-6641-43B3-8BD7-E50420DCEF94 Q26773120-533C4F27-C2E0-46C9-AD94-BC51589CF749 Q26778554-46C12B5A-396A-40BB-8A69-E96849CFE3E8 Q26827655-0F2A5D9B-8664-41AF-A41A-BEB56E899E82 Q26829294-10ACD704-DCC2-4D84-B000-26FC1656E8A8 Q26864102-7E5F56EB-58C6-4EAB-82DA-60D275F170CF Q26866263-31DB9D4F-D0F2-46AC-89B5-0897193CF869 Q26992251-E9964F63-F326-4EF8-920E-5CC5F3B91776 Q27002431-F8FA6F2A-F9E1-4395-9326-5265B92C8599 Q27022366-5B7401D6-F349-4440-A2B9-D37427D632D7 Q27024043-14259F09-71B0-46E2-B2CC-F0D3BC9B42F7 Q27025339-C905C2CA-4A21-4BD2-9093-6DC2F05B8D72 Q27025550-B0183B00-CAB6-4D5B-9097-D76A7CE4831C Q27330325-025E5A95-E120-4882-A0A8-B7E91F65D499 Q27687570-DEAE3B57-281C-426B-BE31-7494863D4F53 Q27687769-1B350770-AF3E-49A5-93B0-B17694E60025 Q28075648-D2731D30-7CB5-4AE1-9705-695D3333AD78 Q28081407-27729FD8-EA2E-4F5C-854E-A626B5450C10 Q28087304-1E6BB184-9D01-4822-82E0-6DD60F3950C3 Q28728330-956E379F-496D-4F2A-A212-AF44F8F7B8C9 Q30234550-BB5B93A7-BF8C-436C-9347-DEF4E12AC659 Q30234751-BEF2C1DA-BA09-446C-A1A6-35B58C0C2792 Q30278441-63E68009-C0F7-4AFF-BFE7-D9C84970E5CA Q30316351-36671CF2-D45A-4EF5-9866-AC5463E43307 Q30410917-2EB68A1F-D0CE-4170-9A46-52557CFFCF71 Q30420798-2AF065C6-2A90-4262-AD10-25326BBCB511 Q33592717-58F1043C-3C71-4D9C-986C-F10F9C29EF50 Q33698598-DE47AB34-ADEB-488D-A0E7-0CFCE0A704E6 Q33703957-72C0E446-4EA2-43AA-B35E-66554BDF6B58 Q33715785-F32E5846-3491-401C-973A-1CA82C7FCAE7 Q33720411-619B789F-C241-435F-B220-AAFCC3C1645C Q33783120-20D9CD3E-1FEF-46E4-BC66-BE1E42DE67CC Q33793927-61716812-F21E-4FE2-A11C-A900705C68E4 Q33835743-F15D3D1C-DAB7-4C88-95C8-2863292BE0BC Q33837633-AD36DE91-9344-41D0-B111-D355DFD43105 Q33873467-44983318-F7B0-4758-89E5-D742733A6BF4 Q33877167-2F7201D5-6CEC-49A8-A11A-D5FA695E2C91

P2860

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

http://www.wikidata.org/entity/Q35099518

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Fibroblast growth factor 23 is ...... ate in chronic kidney disease.

@ast

Fibroblast growth factor 23 is ...... ate in chronic kidney disease.

@en

type

label

Fibroblast growth factor 23 is ...... ate in chronic kidney disease.

@ast

Fibroblast growth factor 23 is ...... ate in chronic kidney disease.

@en

prefLabel

Fibroblast growth factor 23 is ...... ate in chronic kidney disease.

@ast

Fibroblast growth factor 23 is ...... ate in chronic kidney disease.

@en

P1433

Q35099518-1706174E-19EF-4F92-BE87-5B33502468B9

P1476

Q35099518-C478B462-A3F9-4702-831C-A6A3422A20E0

P2093

Q35099518-14342630-E18F-4EE8-9296-2D9A74B700CA

Q35099518-1ABDC194-1322-4759-8A32-3CF022B90F6D

Q35099518-32031C3F-350A-44FE-96B1-F42126DFB991

Q35099518-33A09835-F294-42A2-B7D6-A2A0CE07D2C9

Q35099518-3507CC28-8BA5-4D88-91CD-4EFADFBFB302

Q35099518-35E21DCF-AE77-4265-949F-132F013ADD21

Q35099518-3EE5F2F2-5438-4507-B942-B8A7C55EFFDE

Q35099518-4021DE07-DDF6-423C-9C86-AB3AB9311537

Q35099518-4EEA667E-1713-4B96-ABAC-B0808D58B072

Q35099518-5EB5F47E-4704-4CCA-A2A6-6E7AF5D4FD61

P2860

Q35099518-062B05B5-78C0-4414-8282-FBB98CA6713B

Q35099518-0E8B9A1B-2B72-46DE-829C-4E049020B93F

Q35099518-11BCF598-24C2-4A6C-9B73-526FB6B48FFF

Q35099518-128370E4-10B7-490F-8335-20E025C807C7

Q35099518-350061D5-F54A-48B8-AE26-290E3A73680C

Q35099518-3C8BBB14-82BA-40E6-9DB3-A7B3F157A216

Q35099518-3E38079E-65BA-41B4-A56E-D49FFF2A9753

Q35099518-4455F2FE-964A-45E2-873E-3D6CC48E2373

Q35099518-45D20F3C-77E3-4401-B10B-6FB590DF39E2

Q35099518-4EBEC8C4-1E5C-42EF-878F-1898BA3F5452

P2888

Q35099518-DADBDB46-603A-4A42-A14F-D338AC9B6D0E

P304

Q35099518-595AC3EF-CF63-4E3C-AD3E-39CB6C115C66

P31

Q35099518-B39672F1-0793-40C8-AD20-CF4D8BB5EE09

P356

Q35099518-8E5B2361-F472-42EC-AF4F-5F5AFBBC1FB0

P407

Q35099518-BA291374-D18F-49A8-A70A-AF2ADEC04C1E

P433

Q35099518-C2577B32-CC7F-4BE2-80F2-EA0B1D85AA9D

P478

Q35099518-C616BAD7-1897-4B18-AE6E-C4B9A72E1D32

P577

Q35099518-25CD1FA7-DF59-4E9C-B798-75C3F671F8D2

P5875

Q35099518-EC183300-DC9A-4E90-8720-DFD3D60546A8

P6179

Q35099518-ACAA1825-3DD1-473E-A7EE-673C6A7E34B9

P698

Q35099518-2C761149-A007-4ECA-A914-BA8022F6544E

P932

Q35099518-166C9B12-CB9B-49C6-B208-CB7CC397B2DC

P356

P1433

Kidney International

P1476

Fibroblast growth factor 23 is ...... ate in chronic kidney disease.

@en

P2093

Cheryl A M Anderson

http://www.w3.org/2001/XMLSchema#string

Chi-Yuan Hsu

http://www.w3.org/2001/XMLSchema#string

Crystal Gadegbeku

http://www.w3.org/2001/XMLSchema#string

Dina Appleby

http://www.w3.org/2001/XMLSchema#string

Edward Horwitz

http://www.w3.org/2001/XMLSchema#string

Gabriela S Vargas

http://www.w3.org/2001/XMLSchema#string

Huiliang Xie

http://www.w3.org/2001/XMLSchema#string

James P Lash

http://www.w3.org/2001/XMLSchema#string

Jing Chen

http://www.w3.org/2001/XMLSchema#string

Julia Scialla

http://www.w3.org/2001/XMLSchema#string

P2860

Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system

Klotho converts canonical FGF receptor into a specific receptor for FGF23

FGF23 fails to inhibit uremic parathyroid glands

Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.

Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

P2888

P304

1370-1378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2011.47

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50351998

http://www.w3.org/2001/XMLSchema#string

P6179

1051002414

http://www.w3.org/2001/XMLSchema#string

P698

21389978

http://www.w3.org/2001/XMLSchema#string

P932

3134393

http://www.w3.org/2001/XMLSchema#string